Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05660954 |
|---|---|
| Brief Title: | Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. (CABOTHYROID) |
| First Submitted : | December 2, 2022 |
| First Submitted that Met QC Criteria : | December 14, 2022 |
| First Posted : | December 21, 2022 |
| Last Update Submitted that Met QC Criteria : | August 3, 2023 |
| Last Update Posted : | August 4, 2023 |